2010
DOI: 10.1021/bc100028z
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and in Vitro Antitumor Effect of Vinblastine Derivative−Oligoarginine Conjugates

Abstract: Vinblastine is a widely used anticancer drug with undesired side effects. Its conjugation with carrier molecules could be an efficient strategy to reduce these side effects. Besides this, the conjugate could exhibit increased efficiency against resistant cells, e.g., due to the altered internalization pathway. Oligoarginines, as cell-penetrating peptides, can transport covalently attached compounds into different kinds of cells and enhance the efficiency of those compounds. We report here the coupling of vinbl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
1

Relationship

6
3

Authors

Journals

citations
Cited by 24 publications
(17 citation statements)
references
References 24 publications
0
17
0
Order By: Relevance
“…Vinblastine-16-hydrazide-17-OH was obtained by reaction with hydrazine monohydrate in methanol as described previously. 36 The corresponding hydrazide (0.075 g, 0.1 mmol, 1 eq.) was treated for 10 min with 1-[bis (dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU) (0.046 g, 0.12 mmol, 1.2 eq.…”
Section: A14-vinblastine Construction and Treatment Of Ht-1376 Cellsmentioning
confidence: 99%
“…Vinblastine-16-hydrazide-17-OH was obtained by reaction with hydrazine monohydrate in methanol as described previously. 36 The corresponding hydrazide (0.075 g, 0.1 mmol, 1 eq.) was treated for 10 min with 1-[bis (dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU) (0.046 g, 0.12 mmol, 1.2 eq.…”
Section: A14-vinblastine Construction and Treatment Of Ht-1376 Cellsmentioning
confidence: 99%
“…The obtained conjugates exhibited significant antitumor effect against P388 and L1210 leukemia in mice. At the same time (D)-and (L)-tryptophan derivatives at the 16-position of desacetylvinblastine were conjugated through the carboxyl group with oligoarginine octapeptide as a carrier peptide at the N-terminus by Bánóczi et al [46] One of the obtained stereoisomers showed a selective cytotoxic effect against the HL-60 human leukemia cells of higher proliferation rate.…”
Section: Methodsmentioning
confidence: 99%
“…All the derivatives retained the ability of binding to tubulin and also the antiproliferative activity, which was dependent on the number of arginines. In leukemic cells (HL-60 cell line), the greatest activity (IC 50 ≈ 1.6 µM) was exhibited by the derivative with octa-arginines while the lowest one by the derivative with the shortest oligopeptide (IC 50 ≈ 5 µM) [ 157 ].…”
Section: Microtubule Inhibitorsmentioning
confidence: 99%